Cognizant, in its collaboration with TransCelerate BioPharma Inc. a non-profit organization containing members of global biopharmaceutical companies announced its new Shared Investigator Platform (SIP) for clinical trial researchers. The platform is cloud-based and will help researchers access,Original Article
You may also like
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.